Jiewei Zeng

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Kristian Reich, Henrique D. Teixeira, Marjolein de Bruin‐Weller et al. · The Lancet · 2021 · 389 citations

Medicine, Dermatology, Pediatrics +16

Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results

Jonathan I. Silverberg, Marjolein de Bruin‐Weller, Thomas Bieber et al. · Journal of Allergy and Clinical Immunology · 2021 · 124 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +17

Efficacy and safety results of depatuxizumab mafodotin (ABT‐414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor

Glenwood Goss, Everett E. Vokes, Michael S. Gordon et al. · Cancer · 2018 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended‐Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials

Mohamed‐Eslam F. Mohamed, Jiewei Zeng, Patrick Marroum et al. · Clinical Pharmacology in Drug Development · 2018 · 59 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Network evolution and risk assessment of the global phosphorus trade

Bing Li, Sin Jin Ng, Jing‐Cheng Han et al. · The Science of The Total Environment · 2022 · 45 citations

Natural Sciences, Environmental Sciences, Resource Economics +15